临床试验/NCT02159261

NCT02159261已完成不适用

A Prospective Multicenter Non-interventional Study on Patients and Physicians Satisfaction of Yaz Plus

Bayer0 个研究点目标入组 1,500 人开始时间: 2014年7月15日最近更新: 2017年8月9日

适应症

干预措施

试验速览

阶段: 不适用
状态: 已完成
发起方: Bayer
入组人数: 1,500
主要终点: Satisfaction measured with a Likert response scale (from 1 - poor to 5 - excellent)

研究概览研究设计入排标准研究组 & 干预措施结局指标研究者记录与标识符相似试验

研究概览

简要总结

Local prospective multicenter non-comparative non-interventional observational study. It's planed to assess satisfaction of patients and physicians with results of Yaz Plus treatment for 13 cycles in real practice.

详细描述

Non-interventional, Yaz Plus, Contraception, Assess satisfaction, Russian Federation.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: Female
接受健康志愿者: 是

入选标准

•Female patients ≥ 18 years old
•Requiring contraception
•Prescribed with Yaz Plus for the first time

排除标准

•Contraindications for the use of Yaz Plus in accordance with the local product information

研究组 & 干预措施

Cohort 1

Female patients ≥ 18 years old requiring contraception.

干预措施: BAY98-7071_EE20/DRSP/L-5-MTHF (Drug)

结局指标

主要结局

Satisfaction measured with a Likert response scale (from 1 - poor to 5 - excellent)

时间窗: Up to 12 months

次要结局

Changes in EVAPIL scale for assessment of tolerability of oral contraceptives.(Baseline to 12 months)
Number of participants with adverse events as a measure of safety and tolerability(Up to 12 months)

研究者

发起方

Bayer

申办方类型

Industry

责任方

Sponsor

相似试验

已完成

不适用

Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary HypertensionHypertension, Pulmonary

NCT01971450Bayer89

已完成

不适用

Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation PatientsEmbolismStroke

NCT01925755Bayer209

已完成

不适用

Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus PatientsType 2 Diabetes

NCT02588859AstraZeneca1,200

已完成

不适用

Study to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in IndiaOvarian Cancer

NCT03471572AstraZeneca240

已完成

不适用

Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)Epilepsy

NCT01532726Bial - Portela C S.A.56